コンテンツへスキップ

GeneFrontier ジーンフロンティア株式会社

  • Solutions
    • Koutai Shokunin
      • Overview
      • Price
      • Flow
    • PUREfrex®
      • Overview
      • Lineup
      • Technology
    • PUREfrex® RD
      • Overview
    • Drug Discovery
      • Overview
  • Support
    • Downloads
      • Koutai Shokunin
      • PUREfrex®
      • PUREfrex® RD
    • Cases
      • Koutai Shokunin
      • PUREfrex®
      • PUREfrex® RD
    • News
      • Exhibition
      • Campaign
      • Others
    • FAQ
      • Koutai Shokunin
      • Purefrex®
      • PUREfrex® RD
  • Company
    • Intoroduction
    • Corporate Profile
    • Access
    • Partners
  • Contact
    • General Contact Form
    • Koutai Shokunin Contact Form
    • PUREfrex® Contact Form
検索 検索

日本語

  • 日本語
English

News

  • Home
  • Support
  • News
  • All
  • Exhibition
  • Campaign
  • Others
  • A paper on CTLA-4-binding cyclic peptides and their peptidomimetic small molecules has been published.

    A paper on CTLA-4-binding cyclic peptides and their peptidom……
    Others
    2023.01.05
  • GeneFrontier will present the latest PUREfrex® technology at the conference in PEGS Boston

    May 2 – 6, 2022, Boston, MA & ONLINEPEGS Boston: Confere……
    Exhibition
    2022.04.28
  • Exhibition booth and Poster presentation at Cell Free Systems Conference

    Cell Free Systems ConferenceDecember 4-6, 2019, Boston, MA U……
    Exhibition
    2019.12.10
  • GeneFrontier presented in the poster session for PEGS Boston

    April 08 - 12, 2019, Boston, MAPEGS: the essential protein e……
    Exhibition
    2019.04.26
  • PepTalk-The Protein Science Week

    GeneFrontier presented poster is available.Please visit our ……
    Exhibition
    2018.01.15
  • PUREfrex® 2.1 is newly launched

    PUREfrex® 2.1 is newly launched in December 2017. The selec……
    Others
    2017.12.25
  • GeneFrontier presented in the poster session for PEGS Boston

    GeneFrontier presented our latest and unpublished data in th……
    Exhibition
    2015.05.14
  • GeneFrontier Announces the Second Alliance Regarding PUREfrex RD

    April 22, 2013 GeneFrontier Corporation, a Japan-based biot……
    Exhibition
    2013.04.22
  • Collaboration and License Agreement with the Global Pharmaceutical Company Regarding PUREfrex RD

    Feb. 21, 2013 GeneFrontier Corporation, a Japan-based biote……
    Exhibition
    2013.02.21
  • GeneFrontier Presented at BIO-Europe 2012

    November 12 -14, 2012 BIO-Europe 2012 GeneFrontier introduc……
    Exhibition
    2012.11.29
  • GeneFrontier Presented in Poster Sessions of PEGS 2012

    April 30 – May 4, 2012 Eighth Annual PEGS GeneFrontier intr……
    Exhibition
    2012.05.10
  • GeneFrontier Presented Our Technology at BIO-Europe 2011

    October 31 – November 2, 2011 BIO-Europe® 2011 GeneFrontier……
    Exhibition
    2011.11.15
  • GeneFrontier Presented in Poster Sessions of PEGS 2011

    May 9-13, 2011 Seventh Annual PEGS GeneFrontier introduced ……
    Exhibition
    2011.05.20
  • Solutions
    • Koutai Shokunin
    • PUREfrex®
    • PUREfrex® RD
    • Drug Discovery
  • Support
    • Downloads
    • Cases
    • News
    • FAQ
  • Company
    • Intoroduction
    • Corporate Profile
    • Access
    • Partners
  • Contact
    • General Contact Form
    • Koutai Shokunin Contact Form
    • PUREfrex® Contact Form
  • Recruit
  • Privacy Policy
Copyright © 2023, GeneFrontier Corporation All rights reserved.